Inventor · disambiguated record
Mark Jeroen Kwakkenbos
Also filed as: KWAKKENBOS MARK J · KWAKKENBOS MARK JEROEN
17 granted patents·7 pending applications·61 citations·filing 2010–2024
93Inventor score
Top patents by PatentIndex Score
24 records- 0191US10059757B2RSV-specific binding molecules and means for producing themMEDIMMUNE LTD·Filed 2016·Granted Aug 28, 2018·8 cites·32 claims
- 0290US10730931B2RSV-specific binding molecules and means for producing themMEDIMMUNE LTD·Filed 2018·Granted Aug 4, 2020·3 cites·34 claims
- 0390US8617556B2Gram-positive bacteria specific binding compoundsBEAUMONT TIM·Filed 2011·Granted Dec 31, 2013·12 cites·74 claims
- 0488US9399673B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2013·Granted Jul 26, 2016·7 cites·17 claims
- 0588US9321831B2RSV-specific binding molecules and means for producing themMEDIMMUNE LTD·Filed 2013·Granted Apr 26, 2016·8 cites·23 claims
- 0687US9206247B2Means and methods for producing high affinity antibodiesBEAUMONT TIM·Filed 2011·Granted Dec 8, 2015·7 cites·18 claims
- 0787US9090677B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2013·Granted Jul 28, 2015·6 cites·35 claims
- 0884US9458228B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2015·Granted Oct 4, 2016·3 cites·46 claims
- 0982US9266943B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2013·Granted Feb 23, 2016·3 cites·58 claims
- 1078US9273118B2Means and methods for producing high affinity antibodiesBEAUMONT TIM·Filed 2010·Granted Mar 1, 2016·2 cites·7 claims
- 1178US2024425566A1Ex vivo antibody productionKLING BIOTHERAPEUTICS B V·Filed 2024·Application pending·0 cites
- 1274US9718874B2Influenza A virus specific antibodiesSPITS HERGEN·Filed 2012·Granted Aug 1, 2017·2 cites·9 claims
- 1371US2020325213A1Rsv-specific binding molecules and means for producing themMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 1467US12084681B2Ex vivo antibody productionKLING BIOTHERAPEUTICS B V·Filed 2019·Granted Sep 10, 2024·0 cites·19 claims
- 1566US2018292391A1Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2018·Application pending·0 cites
- 1664US2017009205A1Ex vivo antibody productionAIMM THERAPEUTICS BV·Filed 2014·Application pending·0 cites
- 1763US9927428B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2016·Granted Mar 27, 2018·0 cites·66 claims
- 1862US9688745B2Gram-positive bacteria specific binding compoundsGENENTECH INC·Filed 2015·Granted Jun 27, 2017·0 cites·39 claims
- 1956US2011020323A1Gram-positive bacteria specific binding compoundsBEAUMONT TIM·Filed 2010·Application pending·0 cites
- 2055US10344076B2Means and methods for producing high affinity antibodiesAIMM THERAPEUTICS BV·Filed 2016·Granted Jul 9, 2019·0 cites·9 claims
- 2150US9969795B2Means and methods for producing high affinity antibodiesAIMM THERAPEUTICS BV·Filed 2015·Granted May 15, 2018·0 cites·8 claims
- 2250US2024317880A1Epithelial Cadherin-Specific AntibodiesKLING BIOTHERAPEUTICS B V·Filed 2021·Application pending·0 cites
- 2343US2017313766A1Influenza a virus specific antibodiesAIMM THERAPEUTICS BV·Filed 2017·Application pending·0 cites
- 2435US10611829B2Means and methods for producing stable antibodiesAIMM THERAPEUTICS BV·Filed 2015·Granted Apr 7, 2020·0 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →